Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravitreal Triamcinolone for Acute BRVO
NCT00370266Phase 2Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Feb 2003
- Primary completion
- Oct 2007
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of triamcinolone in macular edema, branch retinal vein occlusion (BRVO), sponsored by Shahid Beheshti University of Medical Sciences. Started Feb 2003; status: completed.
02
Drugs
triamcinolone
03
Conditions
macular edemabranch retinal vein occlusion (BRVO)
Beyond the preview
Go deeper on NCT00370266.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00370266.